Titermax is a mixture of compounds used in antibody generation and vaccination to stimulate the immune system to recognise an antigen given together with the mixture. Titermax is a developed immune adjuvant.
It is a water-in-oil emulsion and consists of squalene, an emulsifier (sorbitan monooleate 80), a patented block copolymer and microparticulate silica (Stills 2005). Toxicity seems to be lower than other water in oil adjuvant such as Freund's adjuvant. The efficacy to elicit an immune response against antigens of low immunogenicity is however subject to debate.
See also
Further reading
- Stills H.F. (2005) "Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants". ILAR Journal. 46(3) 280–293
External links
 | This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
This page was last edited on 11 October 2022, at 21:20